Slojab
2 days ago
A company that's been in existence 13 years and has accomplished absolutely nothing in all that time has the temerity to write such a positive press release with comments like this.
His decision to retire is unrelated to any disagreement with the Company but reflects his desire to conclude his business career with a well-earned retirement.
Again, nothing was accomplished under his chairmanship so what was earned?
During her tenure as CFO, Ms. McWilliams has managed the existing Aluf offerings and has successfully negotiated acquisition agreements with several operating companies with a long history of successful financial performance.
LOL This is genius, I have to admit. Yes, she negotiated agreements. Unfortunately, not a single one was ever consummated, with the exception of Colorocs, which was unwound after a few months. But let's not taint the spin with facts.
Slojab
1 week ago
First order of business for Paresi should be to fire McWilliams. What has she accomplished since 2011?
Teresa McWilliams, Founder and Chief Financial Officer
For more than 30 years, Teresa McWilliams has applied strong analytical skills, strategic planning, and guidance for public, nonprofit, and privately held companies. Since 2011, Ms. McWilliams has been co-leading Aluf Holdings, as Interim Chief Executive Officer, Chief Financial Officer, and Secretary. Currently, as Aluf’s Chief Executive Officer, Ms. McWilliams is responsible for developing and managing acquisitions, growth, financial strategies and regulations, capital generation, and relationships with key financial institutions and private equity firms.
And her only claim to fame is having the company buy her tax prep business. This performance is only possible if you're a public company with a d0-nothing COB and no independent directors. In fact, get rid of the lot of them. Bennett, Striggles and Marks-Canty.
Slojab
1 week ago
Has AHIX found their savior?
Joseph S. Paresi, Chief Executive Officer (Acting)
Mr. Paresi possesses over 45 years of advancement in High Technology-based companies. Mr. Paresi currently advises Aluf’s CEO, Board of Directors and provides leadership in raising capital to improve overall operations and consummate planned Mergers and Acquisitions. Upon the successful completion of funding for one of the company’s acquisitions, Mr. Paresi will join the company’s C-suite as its President and Chief Executive Officer, responsible for overseeing all operations, including cost controls throughout.
Prior to Aluf, Mr. Paresi held roles as the Corporate Director of Technology at Loral and Lockheed Martin, was part of the founding team and Corporate Vice President at L-3 Communications (Now L-3/Harris), Founder of L-3 Security & Detection Systems (Acquired for $1B), and Co founder of L-1 Identity Solutions (acquired for $1.9B).
Mr. Paresi has a Bachelor and Master Degree in Electrical Engineering, MBA/Finance, DoD Program Management Degree and Secret Clearance and Top Secret/Special Compartmental Information Eligible.
Craig305
3 weeks ago
Adding more to the stash!
🚨 $AHIX
💰0.0145
Pink Current, AS: 2.3B, OS: 1.6B, US: 69M
Update Delay: 72 hours
Outstanding Shares Updated:
🔴 1,479,442,476 (2024-05-29)
🟢 1,645,804,476 (2024-06-03)
Difference: +11.2% (+166M)
Restricted Shares Updated:
🔴 1,409,992,093 (2024-05-29)
🟢 1,576,354,093 (2024-06-03)
Difference: +11.8% (+166M)
Slojab
3 weeks ago
I know the SEC turns a blind eye to OTC companies but they really should make an exception in the case of AHIX. All they'd have to do is consider the disparity between their many years of failures to establish or acquire a viable company as well as even retain a CEO for any period of time, and the press releases they put out. Their business description, as well. Both are jokes. Speaking of jokes, there's the salary Teresa McWilliams receives (I won't say earns) for all the past failures.
Consider that the only active business being conducted is the tax prep operation that McWilliams had the company buy from her. A business that loses money. And the market cap for this ticker is over $20,000,000?! Like I said, to protect the public from these people, the SEC should shut them down.
Slojab
4 weeks ago
I wonder who just received 30M shares of restricted stock?
At $.0145, that's a whopping $435,000.
Outstanding Shares Updated:
🔴 1,449,442,476 (2024-05-02)
🟢 1,479,442,476 (2024-05-29)
Difference: +2.1% (+30M)
Restricted Shares Updated:
🔴 1,379,992,093 (2024-05-02)
🟢 1,409,992,093 (2024-05-29)
Difference: +2.2% (+30M)
https://t.me/otcupdates/72378
Slojab
1 month ago
Q1 report is out.
https://www.otcmarkets.com/otcapi/company/financial-report/403113/content
Gross Sales $41,760. And this is the busiest time of the year for tax preparation.
Does anyone think the market cap for this company should be anywhere close to $21,016,916?
I wonder if I ever did the calculation on what AHIX paid McWilliams for her company? I know the Landis's were given 1M restricted shares for their ownership interest but I don't know what %age they owned. At the time of issuance, the shares were at $.0075 making the value of those shares worth just $7500. Seeing how the business loses money every year, I'm surprised they could stay in business as long as they did.
Craig305
2 months ago
What exactly does Held at DTC mean?
The Restricted converted to equivalent Unrestricted...I get that.
How does the Held at DTC then increase by double?
Held at DTC Shares Updated:
🔴 15,834,427 (2024-04-10)
🟢 17,731,451 (2024-05-02)
Difference: +12.0% (+1.9M)
Restricted Shares Updated:
🔴 1,380,992,081 (2024-04-10)
🟢 1,379,992,093 (2024-05-02)
Difference: -0.1% (-999K)
Unrestricted Shares Updated:
🔴 68,450,395 (2024-04-10)
🟢 69,450,383 (2024-05-02)
Difference: +1.5% (+999K)
Slojab
3 months ago
1.9M shares just became unrestricted. I wonder who's shares they were and if they'll be able to sell them.
Restricted Shares Updated:
🔴 1,382,875,105 (2024-02-06)
🟢 1,380,992,081 (2024-04-10)
Difference: -0.1% (-1.9M)
Unrestricted Shares Updated:
🔴 66,567,371 (2024-02-06)
🟢 68,450,395 (2024-04-10)
Difference: +2.8% (+1.9M)
Slojab
3 months ago
Atta girl!
1,449,442,476 as of 12/31/2023
633,049,030 as of 12/31/2022
On October 4, 2023, the company entered into a non-binding Letter of Intent to acquire a company with
thirteen years of developing life science research tools enabling autonomous, non-invasive, real-time
monitoring of compound bioavailability, biological events, or viability/metabolic dynamics from any cell using
a proprietary technology. We have not yet reached adequate terms with the seller and a purchase agreement
has not been signed. No further information regarding the terms of the acquisition available at this time.
On October 18, 2023, the company entered into a non-binding Letter of Intent to acquire a company with over
twenty years pioneering Biometric authentication and Digital Identity Management, specializing in
manufacturing biometric services for identity validation in physical and digital channels, for use in sectors
such as Financial, Government, University, Defense, and Industrial. Due Diligence is well underway; however,
a purchase agreement has been reached and no further information regarding the terms of the acquisition is
available at this time
Tax Partners USA, LLC (acquired December 31, 2022)
Aluf Biometrics, Inc. (not currently operating)
Aluf CBD Partners, LLC. (not currently operating)
Aluf Tech LLC. (not currently operating; formed June 26, 2023)
Cash ..... $500
Gross sales for the entire year .... $65,671
Net loss ...... $171,089
Slojab
5 months ago
For a good laugh, read this from their website. The first one is gibberish. The rest are just plain lies.
Investment Appeal
High-Margin Business Targets – Software and services focused. Does not require capital expense of a hardware manufacturing operation. Can quickly adapt to emerging trends and technologies.
Superior, Sustainable Financial Performance – Acquires only well-established businesses with proven track record of success and financial stability.
Diversified Revenue Mix – Balanced portfolio of evergreen recurring revenue and project-based revenue which delivers smooth, long-term revenue stream for investors while meeting short-term revenue targets.
Highly Experienced Board and Management Team – Best-of-breed team of subject matter experts in each of the areas and verticals the company is focused on. Right people, right timing, right track to success.
Slojab
5 months ago
I've never come across a company press release so filled with self-aggrandizement as this. What have they really said but stayed tuned for news?
There's that word again, renowned. "I do not think that word means what you think it means" to take a quote from The Princess Bride.
"exceptional ability to identify and acquire innovative companies in the biometrics sector"??? How many failures have they had in all the time they've had this ticker? None. Because I don't count Teresa's mom and pop tax prep business.
"leading the charge in industry transformations with a keen focus on groundbreaking technologies in both biotechnology and biometrics." The charge of the light brigade comes to mind.
The whole thing is just more blah, blah, blah, yadda, yadda, yadda and so on and so on. But amusing in a weird sort of way.
Keep up the comedy routine Teresa. You're doing not so well!
Craig305
5 months ago
What a word salad.
Very creative use of fancy words and adjectives for a nothing burger.
Aluf Holdings Inc. Announces Exciting Developments in Biotech and BiometricsPress Release | 01/18/2024
MIAMI, FL / ACCESSWIRE / January 18, 2024 / Aluf Holdings, Inc., (OTC PINK:AHIX) a renowned player in the biometrics industry, is thrilled to announce significant strides in its operations and strategic focus. The company, known for its exceptional ability to identify and acquire innovative companies in the biometrics sector, is now leading the charge in industry transformations with a keen focus on groundbreaking technologies in both biotechnology and biometrics.
Currently, Aluf Holdings is poised to expand its portfolio with a number of major acquisitions, underscored by signed Letters of Intent (LOI). These acquisitions signal the commencement of a new era for Aluf Holdings, marked by a reimagined and rebranded approach geared towards acquiring more disruptive companies within the biotech sector.
These developments come at a time when the global biotech and biometric technology markets are experiencing robust growth. In 2022, the biometric market was valued at USD 34.27 billion, with projections suggesting a compound annual growth rate (CAGR) of 20.4% from 2023 to 2030; while the global biotechnology market, valued at $1.37 trillion in 2022, is projected to grow at a compound annual growth rate of 13.96% from 2023 to 2030. This growth underscores the vast opportunities in these sectors and aligns perfectly with Aluf Holdings' strategic emphasis on biometrics and biotechnology.
Aluf Holdings stands at the forefront of shaping the future of healthcare, contributing to significant advancements in how diseases are diagnosed, and medical breakthroughs are achieved. The company's focus extends beyond financial success, aiming to make a tangible difference in the lives of individuals worldwide.
Investors and stakeholders are invited to join Aluf Holdings on this transformative journey as the company continues to acquire and nurture companies that have the potential to redefine industries and revolutionize lives. With its commitment to capturing bold and life-altering innovations, Aluf Holdings is set to make a profound impact in the realms of biotech and biometrics.
AJH92
5 months ago
Share Structure - Updated January 12, 2024:
Transfer Agent Verified
No change - no dilution
Authorized Shares: 2,299,821,989
Outstanding Shares: 1,411,269,476
- Restricted: 1,344,702,105
- Unrestricted: 66,567,371
Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to current trading.
Note 2: Low Unrestricted Outstanding Shares count - only 66.5M - for a stock in the .0147 > $1+ range.
Craig305
6 months ago
This PR is good for a few laughs.
Enjoy the use of colorful adjectives.
Is just like putting lipstick on a pig!
-----------------
Aluf Holdings Inc. Announces Exciting Developments in Biotech and BiometricsPress Release | 01/08/2024
FORT LAUDERDALE, FL., January 8, 2024 : Aluf Holdings, Inc., (OTC PINK: AHIX) a renowned player in the biometrics industry, is thrilled to announce significant strides in its operations and strategic focus. The company, known for its exceptional ability to identify and acquire innovative companies in the biometrics sector, is now leading the charge in industry transformations with a keen focus on groundbreaking technologies in both biotechnology and biometrics.
Currently, Aluf Holdings is poised to expand its portfolio with a number of major acquisitions, underscored by signed Letters of Intent (LOI). These acquisitions signal the commencement of a new era for Aluf Holdings, marked by a reimagined and rebranded approach geared towards acquiring more disruptive companies within the biotech sector.
These developments come at a time when the global biotech and biometric technology markets are experiencing robust growth. In 2022, the biometric market was valued at USD 34.27 billion, with projections suggesting a compound annual growth rate (CAGR) of 20.4% from 2023 to 2030; while the global biotechnology market, valued at $1.37 trillion in 2022, is projected to grow at a compound annual growth rate of 13.96% from 2023 to 2030. This growth underscores the vast opportunities in these sectors and aligns perfectly with Aluf Holdings strategic emphasis on biometrics and biotechnology.
Aluf Holdings stands at the forefront of shaping the future of healthcare, contributing to significant advancements in how diseases are diagnosed, and medical breakthroughs are achieved. The company's focus extends beyond financial success, aiming to make a tangible difference in the lives of individuals worldwide.
Investors and stakeholders are invited to join Aluf Holdings on this transformative journey as the company continues to acquire and nurture companies that have the potential to redefine industries and revolutionize lives. With its commitment to capturing bold and life-altering innovations, Aluf Holdings is set to make a profound impact in the realms of biotech and biometrics.
AJH92
6 months ago
Share Structure - Updated January 5, 2024:
Transfer Agent Verified
No change - no dilution
Authorized Shares: 2,299,821,989
Outstanding Shares: 1,411,269,476
- Restricted: 1,344,702,105
- Unrestricted: 66,567,371
Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to current trading.
Note 2: Low Unrestricted Outstanding Shares count - only 66.5M - for a stock in the .0109 > $1+ range.
AJH92
6 months ago
Share Structure - Updated December 29, 2023:
Transfer Agent Verified
No change - no dilution
Authorized Shares: 2,299,821,989
Outstanding Shares: 1,411,269,476
- Restricted: 1,344,702,105
- Unrestricted: 66,567,371
Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to current trading.
Note 2: Low Unrestricted Outstanding Shares count - only 66.5M - for a stock in the .01 > $1+ ran
AJH92
6 months ago
Share Structure - Updated December 22, 2023:
Transfer Agent Verified
No change - no dilution
Authorized Shares: 2,299,821,989
Outstanding Shares: 1,411,269,476
- Restricted: 1,344,702,105
- Unrestricted: 66,567,371
Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to current trading.
Note 2: Low Unrestricted Outstanding Shares count - only 66.5M - for a stock in the .01 > $1+ range.